Glaucoma News

High polygenic risk score in individuals with early or suspected glaucoma was associated with a faster rate of peripapillary retinal nerve fiber layer thinning and visual field worsening, a study found.

In a study using two different methods of analysis, the preclinical detectable phase for open-angle glaucoma was estimated to be approximately 10 years, suggesting that a reasonable screening interval could be 5 years.

Faster macular thinning, detected by OCT, was associated with faster subsequent rates of central visual field loss in a study.

Minimally invasive glaucoma surgery is an important technique for ophthalmologists to learn and should be implemented into their practices sooner rather than later, according to a speaker at Real World Ophthalmology.

The FDA approved Iyuzeh for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension, according to a press release from Thea Pharma.

In my ophthalmology residency and also my fellowship, I learned to think about the modification of aqueous dynamics for treatment of glaucoma with respect to inflow (aqueous production) and outflow (aqueous drainage).

The FDA has accepted a new drug application for PDP-716 for the treatment of glaucoma, according to a press release from Visiox Pharma.

A panel of expert glaucoma surgeons reached consensus on patient selection and preoperative, perioperative and postoperative management with the PreserFlo microshunt drainage device.

The risk for progression from anatomical narrow angle to primary angle closure glaucoma is low and mainly occurs within 6 months of ANA diagnosis, according to a poster presented at Real World Ophthalmology.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Osamah Saeedi, MD, discusses the effects of netarsudil on episcleral venous flow in subjects with ocular hypertension and glaucoma suspects.